×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Insider Transactions by Jeff E. Knight

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
CRNXCrinetics Pharmaceuticals, Inc.Jeff E. KnightChief Operating OfficerMar 19, 2025Sale$34.207,162244,96487,852Mar 21, 2025, 06:33 PM
CRNXCrinetics Pharmaceuticals, Inc.Jeff E. KnightChief Operating OfficerNov 22, 2024Sale$56.5250128,31751,653Nov 26, 2024, 04:30 PM
CRNXCrinetics Pharmaceuticals, Inc.Jeff E. KnightChief Operating OfficerJul 15, 2024Option/RSU Exercise$22.5926,073589,11678,653Jul 17, 2024, 05:35 PM
CRNXCrinetics Pharmaceuticals, Inc.Jeff E. KnightChief Operating OfficerJul 15, 2024Sale$55.0027,0001,485,00051,653Jul 17, 2024, 05:35 PM
CRNXCrinetics Pharmaceuticals, Inc.Jeff E. KnightChief Operating OfficerJun 26, 2024Sale$44.3895642,42752,580Jun 28, 2024, 05:31 PM
CRNXCrinetics Pharmaceuticals, Inc.Jeff E. KnightChief Operating OfficerMar 22, 2024Option/RSU Exercise$23.9830,000719,40084,939Mar 26, 2024, 04:30 PM
CRNXCrinetics Pharmaceuticals, Inc.Jeff E. KnightChief Operating OfficerMar 22, 2024Sale$44.3132,3591,433,67554,939Mar 26, 2024, 04:30 PM
CRNXCrinetics Pharmaceuticals, Inc.Jeff E. KnightChief Operating OfficerMar 18, 2024Tax Payment (Shares)$38.144,283163,35454,939Mar 20, 2024, 06:35 PM
CRNXCrinetics Pharmaceuticals, Inc.Jeff E. KnightChief Operating OfficerMar 16, 2023Tax Payment (Shares)$17.1258710,04934,400Mar 17, 2023, 05:08 PM
CRNXCrinetics Pharmaceuticals, Inc.Jeff E. KnightChief Operating OfficerMay 20, 2022Other Acquisition or Disposition$17.441,15220,0916,102Jul 29, 2022, 04:26 PM
CRNXCrinetics Pharmaceuticals, Inc.Jeff E. KnightChief Operating OfficerJul 26, 2022Sale$20.701,15223,8474,950Jul 29, 2022, 04:26 PM